| Chapter title |
Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy
|
|---|---|
| Chapter number | 25 |
| Book title |
Alpha-1 Antitrypsin Deficiency
|
| Published in |
Methods in molecular biology, January 2017
|
| DOI | 10.1007/978-1-4939-7163-3_25 |
| Pubmed ID | |
| Book ISBNs |
978-1-4939-7161-9, 978-1-4939-7163-3
|
| Authors |
Michael Campos, Jorge Lascano, Campos, Michael, Lascano, Jorge |
| Abstract |
Subjects with alpha-1 antitrypsin deficiency who develop pulmonary disease are managed following general treatment guidelines, including disease management interventions. In addition, administration of intravenous infusions of alpha-1 proteinase inhibitor (augmentation therapy) at regular schedules is a specific therapy for individuals with AATD with pulmonary involvement.This chapter summarizes the manufacturing differences of commercially available formulations and the available evidence of the effects of augmentation therapy. Biologically, there is clear evidence of in vivo local antiprotease effects in the lung and systemic immunomodulatory effects. Clinically, there is cumulative evidence of slowing lung function decline and emphysema progression. The optimal dose of augmentation therapy is being revised as well as more individualized assessment of who needs this therapy. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 10 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 2 | 20% |
| Other | 1 | 10% |
| Student > Doctoral Student | 1 | 10% |
| Professor | 1 | 10% |
| Student > Bachelor | 1 | 10% |
| Other | 2 | 20% |
| Unknown | 2 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 30% |
| Biochemistry, Genetics and Molecular Biology | 2 | 20% |
| Agricultural and Biological Sciences | 1 | 10% |
| Chemical Engineering | 1 | 10% |
| Unknown | 3 | 30% |